Measuring Pelvic Organ Prolapse: An Evolution

被引:3
作者
Barber, Matthew D. [1 ]
机构
[1] Duke Univ, Sch Med, Dept Obstet & Gynecol, 203 Baker House,Box 3084, Durham, NC 27720 USA
基金
美国国家卫生研究院;
关键词
Pelvic organ prolapse; Outcome measures; Patient-reported outcomes; Composite outcomes; Measurement; INTERNATIONAL CONTINENCE SOCIETY; PERIOPERATIVE BEHAVIORAL-THERAPY; AMERICAN UROGYNECOLOGIC SOCIETY; OUTCOME MEASURES; ANTERIOR COLPORRHAPHY; GYNECOLOGIC SURGEONS; RANDOMIZED-TRIALS; TRANSVAGINAL MESH; VAGINAL PROLAPSE; STANDARDIZATION;
D O I
10.1007/s00192-024-05798-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction and HypothesisAdvances in our understanding of pelvic organ prolapse (POP) have been made with the introduction of valid, reliable measures of anatomy and patient-reported outcome measures.MethodsThis review provides an overview of the evolution of POP measurement and its implications for clinical practice and research.ResultsSince the introduction of the Pelvic Organ Prolapse Quantification (POPQ), studies have demonstrated that some degree of loss of anatomic support is normal, with as many as 40% of normal women having stage 2 prolapse. Vaginal support is dynamic and can wax and wane but is largely stable over time. Vaginal bulge symptoms are the most reliable and specific symptom for POP and the hymen is an important threshold for symptom development. Most pelvic floor symptoms have only weak to moderate correlation with the anatomic severity of POP. Treatment success rates are highly variable depending upon criteria used and definitions of anatomic success commonly used are too strict and often not clinically relevant. There is substantial discordance between subjective and anatomic measures of success, and both are dynamic, fluctuating between success and failure for many patients without intervening treatment.ConclusionsPelvic organ prolapse is multidimensional, dynamic, and has a complex impact on patients. Patients' symptoms are more clinically relevant than anatomic support. Symptomatic cure, particularly the absence of vaginal bulge symptoms, is more clinically relevant than anatomic cure and composite outcomes can be misleading and overestimate failure rates. Future studies should compare treatments using continuous variables along multiple dimensions rather than using composite outcomes or dichotomizing patients into success or failure.
引用
收藏
页码:967 / 976
页数:10
相关论文
共 58 条
  • [1] Anterior Colporrhaphy versus Transvaginal Mesh for Pelvic-Organ Prolapse
    Altman, Daniel
    Vayrynen, Tapio
    Engh, Marie Ellstrom
    Axelsen, Susanne
    Falconer, Christian
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) : 1826 - 1836
  • [2] Statistics notes - The cost of dichotomising continuous variables
    Altman, DG
    Royston, P
    [J]. BRITISH MEDICAL JOURNAL, 2006, 332 (7549): : 1080 - 1080
  • [3] Making Sense of Composite Endpoints in Clinical Research
    Baracaldo-Santamaria, Daniela
    Feliciano-Alfonso, John Edwin
    Ramirez-Grueso, Raul
    Rojas-Rodriguez, Luis Carlos
    Dominguez-Dominguez, Camilo Alberto
    Calderon-Ospina, Carlos Alberto
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [4] Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?
    Barber, Matthew D.
    Neubauer, Nikki L.
    Mein-Olarte, Victoria
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (04) : 942 - 948
  • [5] Comparison of 2 Transvaginal Surgical Approaches and Perioperative Behavioral Therapy for Apical Vaginal Prolapse The OPTIMAL Randomized Trial
    Barber, Matthew D.
    Brubaker, Linda
    Burgio, Kathryn L.
    Richter, Holly E.
    Nygaard, Ingrid
    Weidner, Alison C.
    Menefee, Shawn A.
    Lukacz, Emily S.
    Norton, Peggy
    Schaffer, Joseph
    Nguyen, John N.
    Borello-France, Diane
    Goode, Patricia S.
    Jakus-Waldman, Sharon
    Spino, Cathie
    Warren, Lauren Klein
    Gantz, Marie G.
    Meikle, Susan F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (10): : 1023 - 1034
  • [6] Defining Success After Surgery for Pelvic Organ Prolapse
    Barber, Matthew D.
    Brubaker, Linda
    Nygaard, Ingrid
    Wheeler, Thomas L., II
    Schaffer, Joeseph
    Chen, Zhen
    Spino, Cathie
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 114 (03) : 600 - 609
  • [7] Symptoms and outcome measures of pelvic organ prolapse
    Barber, MD
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2005, 48 (03) : 648 - 661
  • [8] The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial
    Beard, David J.
    Davies, Loretta J.
    Cook, Jonathan A.
    MacLennan, Graeme
    Price, Andrew
    Kent, Seamus
    Hudson, Jemma
    Carr, Andrew
    Leal, Jose
    Campbell, Helen
    Fitzpatrick, Ray
    Arden, Nigel
    Murray, David
    Campbell, Marion K.
    Barker, Karen
    Murray, Gordon
    Simpson, Hamish
    Dodwell, Donna
    Donell, Simon
    Tavares, Shawn
    Waite, Jonathan
    Arden, Nigel
    Beard, David
    Campbell, Helen
    Carr, Andrew
    Cooper, Cushla
    Davies, Loretta
    Doll, Helen
    Kent, Seamus
    Leal, Jose
    Fusco, Francesco
    Fitzpatrick, Ray
    Murray, David
    Price, Andrew
    Cook, Jonathan
    Campbell, Marion
    Fernie, Gordon
    McDonald, Alison
    Duncan, Anne
    Castillo, Mayret
    Beard, David
    Cook, Jonathan
    Cooper, Cushla
    Davies, Loretta
    Greshon, Akiko
    Holland, Kay
    Li, Jiyang
    Rabaiotti, Elena
    Regan, Sandra
    Stalker, Victoria
    [J]. LANCET, 2019, 394 (10200) : 746 - 756
  • [9] Effect of continuous versus dichotomous outcome variables on study power when sample sizes of orthopaedic randomized trials are small
    Bhandari, M
    Lochner, H
    Tornetta, P
    [J]. ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2002, 122 (02) : 96 - 98
  • [10] Bland DR, 1999, AM J OBSTET GYNECOL, V181, P1324, DOI 10.1016/S0002-9378(99)70371-6